On 9 November 2015, parties in the CVS Caremark Corporation securities litigation (Medoff, Individually and On Behalf of All Others Similarly Situated,  v. CVS Caremark Corporation, et al.) reached an agreement to settle the case.  Plaintiffs alleged that CVS made misstatements in connection with its prescription benefits manager business.  Professor Steven Feinstein of Babson College and Crowninshield Financial Research provided expert reports and deposition testimony about market efficiency, loss causation, and the quantification of shareholder damages.

Additional information is available here.